<?xml version="1.0" encoding="UTF-8"?>
<p>Initial participant recruitment took place prior to the end of the epidemic, and demand to participate in the study at that time was greater than the number of participants needed. To ensure fair subject selection, a lottery system was devised, whereby households were selected and prioritised in an open ballot.
 <sup>
  <xref rid="bibr20-1740774518780678" ref-type="bibr">20</xref>
 </sup> An age de-escalation approach was adopted with safety data being reviewed by an independent data monitoring committee prior to the enrolment of each cohort of children. Pregnant women were excluded because of concerns over the safety of viral vaccines given during pregnancy. This exclusion criterion was common to all Ebola vaccine trials in the region, although some authors have argued that, in future, pregnant women should not be denied the potential benefits of participating in clinical research in an outbreak of such high mortality.
 <sup>
  <xref rid="bibr21-1740774518780678" ref-type="bibr">21</xref>
 </sup>
</p>
